PolymarketVérifier la disponibilitéSans KYC2% de fraisDonnées de résolution vérifiéesAssez bien calibréProbabilité implicite actuelleDecember 53%-10.0pt
Qualite du marche
42 / 100
Faible qualitéVolume 24h
87,9 €
Liquidité
654,7 €
Faible liquiditéAchat / Vente
21.0% / 25.0%
Spread
4.0 pt
Spread modéréVariation 7j
-4.0 pts
Données du marché
Mis à jour il y a 9 minutes
23 juin 26, 2:1331 déc. 26, 23:59
Tendances
Fonds fictifs uniquement, aucun argent réelCeci n'est pas un conseil financier
Résultat choisi
December53%
Tendance du volume
$1003 juil.18j de données28 juil.
Marchés Associés
Will George W Bush outlive Obama?
453,4 €Oui: 12.3%MANIFOLD MARKETS
MANIFOLD MARKETSWill an official mugshot of Anthony Fauci be published before his death?
175,7 €Oui: 8.3%MANIFOLD MARKETS
MANIFOLD MARKETS
Who will Trump nominate as FDA commissioner?
56,9 €Jeffrey Vacirca: 60%
KALSHI
KALSHI
Who will Trump announce as next FDA commissioner?
40,4 €No announcement by December 31: 41%POLYMARKET
POLYMARKET
What will the average number of measles cases be during Trump's term?
19,6 €At least 4500: 43%KALSHI
KALSHIWhen "Will Masking Return"? (widespread mask mandates in the USA)
995,9 €September 2023: 1%MANIFOLD MARKETS
MANIFOLD MARKETSActifs dans ces sujets
Actualités Associées
Polymarket: Vance leads 2028 at 19.85% as pricing trend softensBlockchain.News
White House pushes Senate Democrats to take 'historic' crypto Clarity Act ethics dealCoindesk
Senate nears bipartisan CLARITY Act deal after ethics breakthroughCrypto News
White House agrees to ethics provisions in market structure billCointelegraph
Polymarket odds show Vance at 19.85% as Epstein files critique hits tapeBlockchain.News
Dick Durbin accuses Todd Blanche of shielding Trump’s crypto empireCrypto NewsRègles
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.